Prevalence of RAS and BRAF mutations in metastatic colorectal cancer (mCRC) patients by tumor location.

Bylsma, LC; Gillezeau, C; Garawin, T; Kelsh, MA; Fryzek, J; Sangare, L; Lowe, K

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (4):